• Phenothiazines Boost Macrophage Antibacterial Response via R

  2026-06-16

  The referenced study uncovers how phenothiazines, including dopamine D2 receptor inhibitors, enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy. These findings position host-directed modulation of immune pathways as a promising strategy for combating antibiotic-resistant intracellular infections.

• Thiazovivin (A5506): Protocols for ROCK Inhibition in Stem C

  2026-06-15

  Thiazovivin is a small molecule ROCK inhibitor used to enhance induced pluripotent stem cell (iPSC) generation and support human embryonic stem cell (hESC) survival after trypsinization. It is appropriate for research workflows requiring precision in cell reprogramming or maintenance but is not intended for diagnostic, clinical, or long-term compound storage applications.

• Cyclosporin A in Applied Immunosuppression and Viral Entry R

  2026-06-15

  Cyclosporin A enables precise control of immune responses, apoptosis, and viral entry mechanisms in both cell and animal models. This guide translates cutting-edge research and troubleshooting insights into actionable workflows for autoimmune, mitochondrial, and infection studies.

• Refining In Vitro Drug Response Metrics in Cancer Evaluation

  2026-06-14

  Schwartz's dissertation introduces a nuanced framework for distinguishing cell proliferation arrest from cell death in in vitro cancer drug testing. This approach clarifies the interpretation of anti-cancer agent efficacy and offers practical pathways for more informative preclinical assay design.

• Firefly Luciferase mRNA (5-moUTP): Workflow, Stability & Ass

  2026-06-13

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) streamlines bioluminescent reporter workflows with unmatched translation efficiency and stability. Discover cutting-edge delivery protocols, in-depth troubleshooting, and the latest innovations for robust gene expression studies.

• Biotin-16-UTP: Transforming RNA Detection and Purification W

  2026-06-12

  Biotin-16-UTP empowers researchers to label RNA with precision, unlocking advanced RNA detection, purification, and interaction assays in molecular biology. Optimized for high specificity and robust yield, it streamlines lncRNA mechanistic studies and RNA-protein interaction workflows—key for cutting-edge cancer research.

• ABT-263 (Navitoclax): Transforming Apoptosis Assays in Cance

  2026-06-12

  ABT-263 (Navitoclax) enables precise targeting of Bcl-2 family proteins, driving reliable apoptosis induction across diverse cancer models. This article reveals how to optimize experimental design, troubleshoot workflow bottlenecks, and harness evidence-based innovations from recent patient-derived model studies.

• CD44-Mediated Copper Drives Ly6Chi Macrophage Activation in

  2026-06-11

  This study uncovers a pivotal role for CD44 in mediating copper accumulation, leading to activation of Ly6Chi macrophages and aggravating inflammation in ulcerative colitis. The mechanistic insights into copper metabolism and macrophage function offer new directions for targeted intervention and oxidative stress assay development.

• CDK4/6 and BET Inhibition Synergizes to Suppress EMT in PDAC

  2026-06-11

  Gu et al. (2025) demonstrate that combined inhibition of CDK4/6 and BET proteins synergistically restricts pancreatic tumor progression and reverses epithelial-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight addresses the limitations of CDK4/6 inhibitor monotherapy and suggests a more effective approach for targeting EMT in pancreatic ductal adenocarcinoma.

• Pyridostatin TFA: G-Quadruplex Stabilizer in Cancer & Neurob

  2026-06-10

  Pyridostatin TFA is a synthetic G-quadruplex stabilizer used in telomere biology and cancer cell growth inhibition. It selectively binds G-quadruplex DNA, disrupts telomere function, and demonstrates high selectivity against cancer cell lines. Its mechanism and applications are supported by recent evidence linking G-quadruplex modulation to protein aggregation in neurodegenerative disease.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-06-10

  Harper et al. (2025) reveal that inhibition of RNA polymerase II (RNA Pol II) induces apoptosis through active signaling pathways, independent of transcriptional shutdown. This discovery reframes how cell death is understood in DNA damage response research and may inform future cancer biology workflows.

• Best Practices for Apoptosis Assays Using MCL-1 inhibitor A-

  2026-06-09

  This in-depth guide addresses common laboratory challenges in apoptosis and mitochondrial assays, using MCL-1 inhibitor A-1210477 (SKU B6011) as a model solution. Through real-world scenarios, the article demonstrates evidence-based strategies that enhance reliability and interpretability in cancer research workflows.

• Ceftolozane Sulfate: Precision Antipseudomonal Assays and Cl

  2026-06-09

  Explore the scientific foundations and translational applications of Ceftolozane sulfate in resistant Pseudomonas aeruginosa research. This in-depth guide demystifies its unique PBP3-targeted mechanism and provides actionable insight for assay optimization.

• BIBP 3226 trifluoroacetate: Precision in NPY/NPFF System Res

  2026-06-08

  BIBP 3226 trifluoroacetate empowers researchers to dissect the NPY/NPFF axis with high specificity, unlocking advanced models for anxiety, analgesia, and cardiovascular regulation. Its validated performance in stem cell coculture and signaling pathway studies sets a new benchmark for reproducible discovery.

• Ibuprofen in Translational Cancer Research: Mechanisms and A

  2026-06-08

  Explore the multifaceted role of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) as an anti-proliferative agent in colon cancer research, with advanced insight into its mechanism and assay design. Uncover practical guidance for translational workflows and unique scientific findings.

8077 records 13/539 page Previous Next First page 上5页 1112131415 下5页 Last page